C section News and Research

RSS

Furiex reports financial and operating results for third quarter 2013

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today reported its financial and operating results for the quarter ended September 30, 2013.

6 Nov 2013

Depomed reports financial results for third quarter 2013

Total revenues were $37.5 million and included recognition of a $5.0 million milestone payment from Mallinckrodt related to the NDA filing of MNK-795. Excluding this milestone and a $10 million upfront payment from Janssen in the third quarter of 2012, total revenues of $32.5 million grew 39% compared to $23.3 million for the third quarter of 2012.

6 Nov 2013

Jazz Pharmaceuticals announces third quarter financial results and updated 2013 guidance

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2013 and updated 2013 financial guidance.

6 Nov 2013

RGTS launches multi-vendor Healthcare Mobile Technology Roadshow

Rockefeller Group Technology Solutions, Inc., a division of Rockefeller Group International, Inc., today announced the launch of a multi-vendor Healthcare Mobile Technology Roadshow throughout the tri-state region.

5 Nov 2013

Study: Clinicians' decision making could be affected by method of conception

Parents who conceive through assisted reproductive technologies are likely to receive different medical advice in relation to prenatal testing than those who conceive naturally, academics have suggested.

5 Nov 2013

Accretive Health plans to provide restatement and business update on November 13, 2013

Accretive Health, Inc. (NYSE: AH) plans to provide a business update and an update on the status of the restatement of the company's financial statements after the market closes on November 13, 2013, and will host a call on the same day at 4:00 p.m. CST (5:00 p.m. EST) to discuss the update.

5 Nov 2013

Age-friendly NYC wins APHA's 2013 Archstone Foundation Award for Excellence in Program Innovation

The American Public Health Association has recognized the vision and innovation of Age-friendly NYC with its 2013 Archstone Foundation Award for Excellence in Program Innovation. The award will be presented to Dorian Block, Manager of Age-friendly NYC, during the APHA's Public Health Awards Reception and Ceremony on Tuesday, November 5, 2013.

5 Nov 2013

Viewpoints: Website is like 'a patient bleeding from self-inflicted wounds;' remembering patients who never had care and the need for health law

Obamacare is starting to resemble a patient bleeding from self-inflicted wounds. A month after launch, the online health exchanges where individuals are supposed to shop for insurance remain slow or unusable, except in states that opted to run their own marketplaces and did a more competent job than the administration. As if that weren't trouble enough, critics are justifiably mocking President Obama for his repeated, untrue promise that if people liked their health plans, they could keep them. Oops. Hundreds of thousands of people are getting termination notices for plans that don't meet the strict new requirements of the Affordable Care Act. Presumably, not all those people disliked their plans (11/3).

5 Nov 2013

CHFA launches five-part guide to help Canadians make informed decisions about natural health

To celebrate Natural Health Products Week, the Canadian Health Food Association is launching a free, five-part guide aimed at helping Canadian families make informed decisions about natural health. The Canadian Family's Guide to Navigating Natural Health, was developed with nutritionist and author Lianne Phillipson-Webb.

4 Nov 2013

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

In recognition of November as National Diabetes Month, the American College of Occupational and Environmental Medicine (ACOEM) is urging employers to identify and respond to the impact of diabetes on worker health and productivity.

4 Nov 2013

Lawmakers don't have to say which staffers have to use health exchange

Members of Congress can choose who -- if any -- among their staffs go on the health law's insurance exchange.Sen. David Vitter, R-La., objects to the fact that they don't have to announce those decisions.

4 Nov 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.

31 Oct 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

Safe sleep environment can reduce risk of Sudden Infant Death Syndrome

On the cover of a popular consumer magazine, the latest celebrity mom holds her adorable newborn. The centerfold is emblazoned with images of the baby's nursery with a crib filled with soft, frilly bedding, pillows and stuffed animals. Barbara Ostfeld cringes; the photos perpetuate a message she is trying to dismantle. The overstuffed crib, with all its beautiful accessories, is an unsafe sleeping environment for an infant.

30 Oct 2013

MiMedx Group reports record revenue in third quarter 2013

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

30 Oct 2013

Wiley expands partnership with EMBO

John Wiley & Sons, Inc., today announced that it will provide editorial production, global marketing and distribution services for The EMBO Journal, EMBO reports and Molecular Systems Biology. This expanded partnership with EMBO adds three leading scientific journals alongside EMBO Molecular Medicine, which Wiley has published since 2009.

30 Oct 2013

Enterocystoplasty: A good surgical option for children with genitourinary abnormalities

Enterocystoplasty is a good surgical option with a low rate of severe complications in the treatment of children who were born with developmental abnormalities of the genitourinary system, according to the new study conducted by a group of Portuguese urologists.

30 Oct 2013

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

If you've ever been sleep-deprived, you've probably had a firsthand glimpse of the blood vessels in your eyes. But what you haven't seen—and what many eye care professionals cannot see as well as they would like—are the vessels closest to the retina, the light-sensitive tissue at the back of the eye.

29 Oct 2013

Leading surgical specialists outline approaches to laparoscopic paraesophageal hernia repair

Minimally invasive surgical techniques have revolutionized the treatment paraesophageal hernia-but there's continued controversy over some key technical aspects of the procedure.

29 Oct 2013

Penn Medicine researchers show predictive power of overlooked lymph nodes

For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes--known as the posterior intercostal lymph nodes--that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.

29 Oct 2013

C section News and Research

Furiex reports financial and operating results for third quarter 2013

Depomed reports financial results for third quarter 2013

Jazz Pharmaceuticals announces third quarter financial results and updated 2013 guidance

RGTS launches multi-vendor Healthcare Mobile Technology Roadshow

Study: Clinicians' decision making could be affected by method of conception

Accretive Health plans to provide restatement and business update on November 13, 2013

Age-friendly NYC wins APHA's 2013 Archstone Foundation Award for Excellence in Program Innovation

Viewpoints: Website is like 'a patient bleeding from self-inflicted wounds;' remembering patients who never had care and the need for health law

CHFA launches five-part guide to help Canadians make informed decisions about natural health

ACOEM urges employers to respond to the impact of diabetes on worker health and productivity

Lawmakers don't have to say which staffers have to use health exchange

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Safe sleep environment can reduce risk of Sudden Infant Death Syndrome

MiMedx Group reports record revenue in third quarter 2013

Wiley expands partnership with EMBO

Enterocystoplasty: A good surgical option for children with genitourinary abnormalities

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

Leading surgical specialists outline approaches to laparoscopic paraesophageal hernia repair

Penn Medicine researchers show predictive power of overlooked lymph nodes

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News